| scholarly article | Q13442814 |
| P2093 | author name string | Chun Zhang | |
| Hui Tang | |||
| Hua Su | |||
| Pan Gao | |||
| Shan Chen | |||
| Fang-Fang He | |||
| Xian-Fang Meng | |||
| Chun-Tao Lei | |||
| P2860 | cites work | The Nalp3 inflammasome is essential for the development of silicosis | Q24645580 |
| Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy | Q27488746 | ||
| Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
| A role for mitochondria in NLRP3 inflammasome activation | Q28131794 | ||
| Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3 | Q28248159 | ||
| Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein | Q28260396 | ||
| Oxidative stress as a major culprit in kidney disease in diabetes | Q28281957 | ||
| Cryopyrin activates the inflammasome in response to toxins and ATP | Q28291313 | ||
| Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function | Q28506375 | ||
| Osthole mitigates progressive IgA nephropathy by inhibiting reactive oxygen species generation and NF-κB/NLRP3 pathway | Q28534656 | ||
| Thioredoxin-interacting protein links oxidative stress to inflammasome activation | Q29614471 | ||
| Oxidative Stress and Diabetic Complications | Q29615423 | ||
| Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants | Q29615635 | ||
| NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? | Q29619524 | ||
| P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway | Q30409205 | ||
| Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene | Q33729668 | ||
| Redox signaling via lipid raft clustering in homocysteine-induced injury of podocytes | Q33733309 | ||
| High glucose induces podocyte apoptosis by stimulating TRPC6 via elevation of reactive oxygen species | Q34053587 | ||
| The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. | Q34455462 | ||
| A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy. | Q53545278 | ||
| Glomerular cell number in normal subjects and in type 1 diabetic patients | Q57500168 | ||
| Renal involvement in secondary amyloidosis of Muckle-Wells syndrome: marked improvement of renal function and reduction of proteinuria after therapy with human anti-interleukin-1β monoclonal antibody canakinumab | Q58326117 | ||
| Glomerular cell number in normal subjects and in type 1 diabetic patients | Q73942888 | ||
| Interleukin-1-receptor antagonist in type 2 diabetes mellitus | Q80624568 | ||
| Superoxide dismutase 1 regulates caspase-1 and endotoxic shock | Q81588114 | ||
| Thioredoxin-interacting protein mediates NALP3 inflammasome activation in podocytes during diabetic nephropathy | Q87391789 | ||
| Thioredoxins and glutaredoxins: unifying elements in redox biology | Q34998212 | ||
| Vitamin D3 upregulated protein 1 (VDUP1) is a regulator for redox signaling and stress-mediated diseases | Q36623251 | ||
| NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia | Q36731427 | ||
| Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease | Q36788430 | ||
| Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome | Q36909900 | ||
| Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia | Q37121306 | ||
| Expression, localization, and function of the thioredoxin system in diabetic nephropathy | Q37146420 | ||
| Contribution of guanine nucleotide exchange factor Vav2 to hyperhomocysteinemic glomerulosclerosis in rats | Q37151470 | ||
| Up-regulation of thioredoxin interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to the impaired thioredoxin activity and increased ROS in glucose-treated endothelial cells | Q37179758 | ||
| Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure | Q37298478 | ||
| The NLRP3 inflammasome: a sensor for metabolic danger? | Q37675505 | ||
| Reactive oxygen species and antioxidant machinery in abiotic stress tolerance in crop plants | Q37792599 | ||
| The thioredoxin system as a therapeutic target in human health and disease. | Q38067821 | ||
| Thioredoxin-interacting protein mediates ER stress-induced β cell death through initiation of the inflammasome | Q39299566 | ||
| Role of CD2-associated protein in albumin overload-induced apoptosis in podocytes | Q39618941 | ||
| Differing caspase-1 activation states in monocyte versus macrophage models of IL-1beta processing and release | Q40538072 | ||
| Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells | Q40628313 | ||
| Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation | Q41888241 | ||
| Caspase-1-deficient mice are protected against cisplatin-induced apoptosis and acute tubular necrosis | Q45166196 | ||
| Comment on: Thallas-Bonke et al. (2008) Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway: Diabetes 57:460-469, 2008. | Q46568335 | ||
| Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney | Q46681131 | ||
| Role of apoptosis signal-regulating kinase 1 in complement-mediated glomerular epithelial cell injury | Q46820717 | ||
| Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy | Q46870214 | ||
| A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection | Q48108353 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | hyperglycemia | Q271993 |
| inflammasome complex | Q412405 | ||
| P304 | page(s) | 504761 | |
| P577 | publication date | 2015-03-05 | |
| P1433 | published in | Journal of Diabetes Research | Q26841822 |
| P1476 | title | NADPH oxidase-induced NALP3 inflammasome activation is driven by thioredoxin-interacting protein which contributes to podocyte injury in hyperglycemia | |
| P478 | volume | 2015 |
| Q38844514 | ASK1: a new therapeutic target for kidney disease |
| Q47166089 | Activation of NLRP3 Inflammasome by Advanced Glycation End Products Promotes Pancreatic Islet Damage |
| Q36928482 | Cold-inducible RNA-binding protein causes endothelial dysfunction via activation of Nlrp3 inflammasome |
| Q41662846 | Deletion of TXNIP Mitigates High-Fat Diet-Impaired Angiogenesis and Prevents Inflammation in a Mouse Model of Critical Limb Ischemia. |
| Q42571594 | Erratum to "NADPH Oxidase-Induced NALP3 Inflammasome Activation Is Driven by Thioredoxin-Interacting Protein Which Contributes to Podocyte Injury in Hyperglycemia". |
| Q38713406 | High fat diet dysregulates microRNA-17-5p and triggers retinal inflammation: Role of endoplasmic-reticulum-stress. |
| Q91651940 | IgA1 deposition may induce NLRP3 expression and macrophage transdifferentiation of podocyte in IgA nephropathy |
| Q38931056 | Inflammasome Activation in Chronic Glomerular Diseases |
| Q26740458 | Inflammasomes in the Pathophysiology of Kidney Diseases |
| Q38633495 | Innate immunity in diabetes and diabetic nephropathy |
| Q38717704 | NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients. |
| Q45057004 | NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury |
| Q38837256 | Oxalate, inflammasome, and progression of kidney disease |
| Q53176987 | Radiation-induced inflammation and autoimmune diseases. |
| Q55266333 | Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis. |
| Q42876331 | Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes |
| Q92711301 | Roles of Inflammasomes in Inflammatory Kidney Diseases |
| Q42351011 | Supplemental N-acetylcysteine and other measures that boost intracellular glutathione can downregulate interleukin-1β signalling: a potential strategy for preventing cardiovascular events? |
| Q52575760 | Sweet Taste Receptors Mediated ROS-NLRP3 Inflammasome Signaling Activation: Implications for Diabetic Nephropathy. |
| Q26740429 | The Nucleotide Oligomerization Domain-Like Receptors in Kidney Injury |
| Q52371823 | Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and Neurodegenerative Diseases: Regulation and Implication. |
Search more.